Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a shortage of the brand-name drug has ended – which means compounding of the medicine must stop.
Weight-loss drugs lower impulse to eat – and perhaps to exercise too
Popular weight-loss medications including Ozempic and Wegovy contain a drug that seems to decrease cravings for food and drugs – and now there’s evidence that it might make exercise less rewarding, to
Health plans at 1 in 5 large companies cover weight-loss drugs for employees
Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance plans, a new survey shows.
Most U.S. employers don’t cover weight loss drugs — and fewer plan on doing so
Less than a fifth of large employers in the U.S. include coverage for the popular but pricey weight loss drugs Wegovy and Zepbound, a KFF survey finds.
Your employer may start covering weight-loss drugs soon
Still, more than a quarter of employers are considering adding coverage for GLP-1 drugs for weight loss in 2025 or 2026, according to a national survey conducted this year by Mercer, a human resources consulting firm.
Only 1 in 5 Large Companies' Health Plans Cover New Weight-Loss Meds for Employees
When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies cover the medications in their health insurance plans, a new survey shows. In a report published Wednesday in the journal Health Affairs,
Drug makers sue FDA so they can keep making knockoff weight-loss drugs
But FDA says it's over. Compounding pharmacies are suing the Food and Drug Administration so they can keep making imitation versions of popular—and lucrative—tirzepatide drugs, namely knockoffs of Mounjaro for diabetes and Zepbound for weight loss.
Popular Weight Loss Drugs To Become More Expensive As Shortage Ends
With the shortage over, compounding pharmacies are no longer allowed to produce the popular weight loss drugs.
28m
California police department buys Cybertruck to keep kids off drugs
Sure, Tesla's Cybertruck looks something a person using hallucinogens might imagine. But a police department in California is ...
New Atlas
18h
"Embarrassingly simple" tag puts IV chemotherapy drugs in pill form
Taking a pill is the easiest, least invasive way to take medicine, but unfortunately, not all drugs work that way. Now, ...
8h
US releases preliminary list of $2 generic drugs for Medicare recipients
The U.S. Centers for Medicare & Medicaid Services released on Wednesday a preliminary list of 101 generic drugs that would be ...
2h
Louisville Black Man Accused of Driving With Drugs Gets Big Payday From the City
Nearly six years after Marlo Brown was wrongly frisked and threatened by Louisville police, he’s finally getting some justice ...
34m
on MSN
Former Houston Drug Cop Gets 60 Years for His Deadly Lies
Gerald Goines, the mendacious former Houston narcotics officer who had a habit of framing drug suspects, received two ...
4h
Ozempic underworld: Inside the black market of obesity drugs
A CNBC investigation into counterfeit weight-loss drugs revealed an international illegal marketplace where criminals either alter the drugs or ship the real product from overseas.
1d
on MSN
With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time to Buy Eli Lilly Stock?
While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.
1d
on MSN
New strategy could turn intravenous medicines into pills
For many people with cancer, intravenous (IV) infusions of chemotherapy are their best chance at a cure. But these infusions ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback